Goldman Sachs Group »

Seres Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $483k 667k 0.72
2024-03-31 $824k 1.1M 0.77
2023-12-31 $610k 436k 1.40
2023-09-30 $1.7M 701k 2.38
2023-06-30 $3.1M 657k 4.79
2023-03-31 $1.8M 321k 5.67
2022-12-31 $1.9M 334k 5.60
2022-06-30 $2.0M 572k 3.43
2022-03-31 $5.2M 729k 7.12
2021-12-31 $10M 1.2M 8.33
2021-09-30 $4.0M 572k 6.96
2021-03-31 $19M 909k 20.59
2020-12-31 $18M 745k 24.50
2020-09-30 $17M 582k 28.30
2020-06-30 $1.7M 366k 4.76
2019-12-31 $565k 164k 3.45
2019-09-30 $459k 114k 4.01
2019-06-30 $2.0M 628k 3.22
2019-03-31 $743k 108k 6.87
2018-12-31 $313k 69k 4.52
2018-09-30 $613k 81k 7.59
2018-06-30 $621k 72k 8.60
2018-03-31 $297k 41k 7.33
2017-12-31 $502k 50k 10.14
2017-09-30 $460k 29k 16.03
2017-06-30 $263k 23k 11.28
2017-03-31 $501k 44k 11.28
2016-12-31 $352k 36k 9.90
2016-09-30 $244k 20k 12.28
2016-06-30 $424k 15k 29.05
2016-03-31 $3.4M 128k 26.56
2015-12-31 $3.2M 91k 35.07
2015-09-30 $1.6M 55k 29.68